Targeted specialties Cardiologists Neurologists General Physicians Diabetologists Nutritionists / Dietitians Endocrinologists Disclaimer : To be administered only under the supervision of a qualified healthcare professional
James BD, Wilson RS, Capuano AW, et al
CrossRef A Comprehensive Insight Into the Roles of Exosomal circRNAs in Metabolic Syndrome Azadeh Taherpour, Safieh Ebrahimi, Farshad Mirzavi BioFactors.2025;[Epub] CrossRef Basic and Translational Research Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies Joon Seok Park, Kyu Sik Kim, Hyung Jin Choi Diabetes Metab J
The compounds discussed, including Dihexa, are not approved by the FDA for human or veterinary use
These limitations highlight the necessity for carefully designed future trials targeting appropriate disease stages and patient populations
Tirzepatide mimics both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), a mechanism the brand positions as offering "deeper, sustained progress." Per Omzo's Terms, initial tirzepatide consultation and supply is priced at $349/month (originally $259 per the brand - verify at checkout)
